Where is BD Corporate office Headquarters
BD Headquarters Address and Contact
BD Headquarters Location & Directions
BD Headquarters Executive Team
Vincent A. Forlenza
Chairman & CEO
Thomas E. Polen Jr.
Christopher R. Reidy
Executive VP, CFO & Chief Administrative Officer
James W. Borzi
Executive VP of Global Operations & Chief Supply Chain Officer
Gary M. Cohen
Executive VP of Social Innovation & President of BD Foundation
President of Worldwide Medication & Procedural Solutions
Executive VP & President of EMEA
Patrick K. Kaltenbach
President of the Life Sciences Segment
Executive VP & President of Greater Asia
President of the Medical Segment
About BD, History and Headquarters Information
BD was founded in the year 1897. The company has been operational for almost 122 years now. The founders of the company were Fairleigh S Dickinson and Maxwell W Becton. The company had made its first sale in the year of its founding, which was a Luer-all-glass syringe, for an amount of $2.50. In the year 1898, the company had acquired its first patent. The following year, the company had introduced its first logo as well. Then in the year 1904, the company had received the Philadelphia Surgical Company. In the year 1906, the company had established a manufacturing facility in East Rutherford for the production of various kinds of hypodermic needles, thermometers, syringes, etcetera. In the year 1924, the company had manufactured its first syringe for the injection of insulin.
Then in the year 1949, the company had opened a new manufacturing facility in Connecticut, USA. The company soon expanded to Canda, along with Mexico, France as well as Brazil. During the year 1950, the company had developed the first sterile disposable product, which was a blood collection set and was sold to the American Red Cross. In the year 1954, the company had introduced a complete disposable syringe made from glass, which was known as BD Hypak. In the year 1962, the company was converted into a limited public entity and also appeared in the Fortune 500 companies list in 1970. In the year 1973, the company had added another USA facility in North Carolina, USA. During the year 1975, the company had acquired an essential patent for a syringe prefilled for the injection of heparin. Then in the year 1980, the company had developed its first automated system for the testing of mycobacteria. The sales of the company had crossed almost $1 billion the following year. In the year 1986, the company had taken over Fabersanitas Industrial, which was a significant producer of syringes in the market of Spain. The company had also opened up manufacturing facilities in Japan and Singapore. The company had opened up distribution centres in Belgium during the year 1992 and in China and India during 1995. In the year 1999, the company had acquired Biometric Imaging. During the year 2000, the company had started the BD Safety Compliance Initiative by pledging almost $1 million to the International AIDS Vaccine Initiative. The company was also responsible for the development of the world's first intelligent glucose monitoring system as well as an insulin pump monitoring system as well. Then in the year 2004, the company had acquired Atto Bioscience Acquired - a company which specialised in optical cells. As of the year 2005, the company had entered the Proteomics market by taking over of FFE Weber GmbH. The headquarters of the company is based in 1 Becton Drive. The name of the place is Franklin Lakes, while the name of the state is New Jersey, USA. The pin code of the area is 07417.
BD is an American company that focuses on the research and development of various kinds of medical technology, that helps in serving various life sciences researchers, healthcare institutions, the medical industry and as well as the clinical laboratories too. The current CEO and chairman of the company are Vincent A Forlenza. As of the year 2018, the total revenue generated by the company is more than $15.9 billion. Also, the number of employees working at the company is more than 76,000. The company has its presence in over 50 countries all over the world. The company is currently ranked at number 251 in the Fortune 500 companies list.
The primary services provided by the company include the research and development of medical science, in order to improve the delivery of various kinds of drugs, improving the diagnosis of numerous infection diseases, treatment of cancer, advancement in cellular research and also support the management of diabetes.